Treatment Guidelines from The Medical Letter
FROM
ISSUE
91
March 1, 2010
View Complete Issue         Table of Contents 2019 
Drugs for Cognitive Loss and Dementia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Cognitive Loss and Dementia
March 1, 2010 (Issue: 91)
Alzheimer’s disease (AD) is the most common form of dementia, but cognitive loss is also associated with other neurological conditions such as Parkinson’s disease, dementia with Lewy bodies or vascular dementia. Mild cognitive impairment (MCI)...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Cognitive Loss and Dementia
Article code: 91a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.